Development of a drug-eluting microstent for micro-invasive glaucoma surgery

Glaucoma represents the leading cause of irreversible blindness worldwide. Therapeutic approaches are based on the lowering of intraocular pressure (IOP). Micro-invasive glaucoma surgery (MIGS) offers perspectives for implant based IOP-reduction with reduced complication rates compared to convention...

Full description

Bibliographic Details
Main Authors: Siewert Stefan, Pfensig Sylvia, Großmann Swen, Stiehm Michael, Schmitz Klaus-Peter, Schmidt Wolfram, Kohse Stefanie, Wulf Katharina, Grabow Niels, Kopp Franziska, Guthoff Rudolf
Format: Article
Language:English
Published: De Gruyter 2018-09-01
Series:Current Directions in Biomedical Engineering
Subjects:
Online Access:https://doi.org/10.1515/cdbme-2018-0145

Similar Items